Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (4343)	5/19/1998 6:32:00 PM
From: sam	Respond to of 6136

Here's Merrill Lynch's rating system, in order: Buy Accumulate Neutral Reduce Sell No Rating

To: Izzy who wrote (4343)	5/19/1998 6:33:00 PM
From: Steve Fancy	Read Replies (2) \| Respond to of 6136

Izzy the coverage initiated today was Accumulate and Long Term Accumulate. Merrill's rating system is buy, accumulate, neutral, reduce, sell, no rating. Based on this, accumulate sits between buy and neutral. The actual rating is D-2-2-9, which translates into High Risk, Int. term accumulate, long term accumulate, no cash dividend. I did not post some financials, but posted everything else. Looks like we can figure out royalty situations from the financial data they included. Will try and post later. sf